Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this observational study is to evaluate the
efficacy on blood glucose control while using NovoMix® 30 FlexPen® under normal clinical
practice conditions in Korea. A clinical safety profile will be also evaluated.